Bioventix Plc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioventix Plc with three other
companies in this sector in the United Kingdom:
sales of £5.06 million [US$6.59 million]
of which 40%
was Preclinical Research services),
Puretech Health Plc
(£3.30 million [US$4.29 million]
of which 92%
was Growth stage operating companies), and
Midatech Pharma PLC
(£6.92 million [US$9.01 million]
of which 81%
During the year ended June of 2016, sales at
Bioventix Plc were £5.52 million (US$7.18 million).
increase of 27.3%
versus 2015, when the company's sales were £4.33 million.
This was the fifth consecutive year of sales increases at Bioventix Plc
(and since 2011, sales have increased a total of 180%).